226 related articles for article (PubMed ID: 18347637)
1. Management of Coats disease with bevacizumab in 2 patients.
Venkatesh P; Mandal S; Garg S
Can J Ophthalmol; 2008 Apr; 43(2):245-6. PubMed ID: 18347637
[No Abstract] [Full Text] [Related]
2. Juxtafoveal telangiectasias.
Querques G; Delle Noci N
Ophthalmology; 2008 Sep; 115(9):1636; author reply 1636. PubMed ID: 18762079
[No Abstract] [Full Text] [Related]
3. Intravitreal bevacizumab therapy for idiopathic macular telangiectasia.
Matsumoto Y; Yuzawa M
Jpn J Ophthalmol; 2010 Jul; 54(4):320-4. PubMed ID: 20700800
[TBL] [Abstract][Full Text] [Related]
4. Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia.
Rishi P; Rishi E; Shroff D
Indian J Ophthalmol; 2009; 57(3):241-2. PubMed ID: 19384026
[No Abstract] [Full Text] [Related]
5. Intravitreous ranibizumab as treatment for macular telangiectasia type 2.
Lira RP; Silva VB; Cavalcanti TM; de Souza AC; Pinto AP
Arch Ophthalmol; 2010 Aug; 128(8):1075-8. PubMed ID: 20697014
[No Abstract] [Full Text] [Related]
6. Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia.
Charbel Issa P; Holz FG; Scholl HP
Ophthalmology; 2007 Sep; 114(9):1736-42. PubMed ID: 17822979
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab compared with photodynamic therapy with verteporfin for group 2a parafoveal retinal telangiectasis.
Windisch R; Kozousek V
Can J Ophthalmol; 2008 Aug; 43(4):489-90. PubMed ID: 18711474
[No Abstract] [Full Text] [Related]
8. The article by Kovach and Rosenfeld.
Charbel Issa P; Holz FG; Scholl HP
Retina; 2009 May; 29(5):717; author reply 717-8. PubMed ID: 19430284
[No Abstract] [Full Text] [Related]
9. Intravitreal bevacizumab for macular edema from idiopathic juxtafoveal retinal telangiectasis.
Moon SJ; Berger AS; Tolentino MJ; Misch DM
Ophthalmic Surg Lasers Imaging; 2007; 38(2):164-6. PubMed ID: 17396701
[TBL] [Abstract][Full Text] [Related]
10. Resolution of severe macular edema in adult coats' disease with intravitreal triamcinolone and bevacizumab injection.
Jun JH; Kim YC; Kim KS
Korean J Ophthalmol; 2008 Sep; 22(3):190-3. PubMed ID: 18784449
[TBL] [Abstract][Full Text] [Related]
11. Resolution of macular edema in Coats' disease with intravitreal bevacizumab.
Entezari M; Ramezani A; Safavizadeh L; Bassirnia N
Indian J Ophthalmol; 2010; 58(1):80-2. PubMed ID: 20029156
[TBL] [Abstract][Full Text] [Related]
12. Combined intravitreal bevacizumab and argon laser treatment for Coats' disease.
Cackett P; Wong D; Cheung CM
Acta Ophthalmol; 2010 Mar; 88(2):e48-9. PubMed ID: 19500078
[No Abstract] [Full Text] [Related]
13. Bevacizumab in the treatment of idiopathic macular telangiectasia.
Gamulescu MA; Walter A; Sachs H; Helbig H
Graefes Arch Clin Exp Ophthalmol; 2008 Aug; 246(8):1189-93. PubMed ID: 18386039
[TBL] [Abstract][Full Text] [Related]
14. Bevacizumab (avastin) therapy for idiopathic macular telangiectasia type II.
Kovach JL; Rosenfeld PJ
Retina; 2009 Jan; 29(1):27-32. PubMed ID: 18936721
[TBL] [Abstract][Full Text] [Related]
15. Elevated vascular endothelial growth factor level in Coats' disease and possible therapeutic role of bevacizumab.
He YG; Wang H; Zhao B; Lee J; Bahl D; McCluskey J
Graefes Arch Clin Exp Ophthalmol; 2010 Oct; 248(10):1519-21. PubMed ID: 20379736
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation.
Meyerle CB; Freund KB; Iturralde D; Spaide RF; Sorenson JA; Slakter JS; Klancnik JM; Fisher YL; Cooney MJ; Yannuzzi LA
Retina; 2007; 27(4):451-7. PubMed ID: 17420697
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab and macular edema.
Kumar A
Ophthalmology; 2008 Mar; 115(3):585. PubMed ID: 18319106
[No Abstract] [Full Text] [Related]
18. Bevacizumab and retinal ischemia.
Neubauer AS; Kook D; Haritoglou C; Priglinger SG; Kampik A; Ulbig MW; Ceklic L
Ophthalmology; 2007 Nov; 114(11):2096. PubMed ID: 17980746
[No Abstract] [Full Text] [Related]
19. The effect of intravitreal bevacizumab in the treatment of Coats disease in children.
Lin CJ; Hwang JF; Chen YT; Chen SN
Retina; 2010 Apr; 30(4):617-22. PubMed ID: 19996822
[TBL] [Abstract][Full Text] [Related]
20. Comment of article by Matsumoto Y.
Campa C; D'Angelo S; Incorvaia C
Retina; 2008 May; 28(5):782; author reply 782-3. PubMed ID: 18463528
[No Abstract] [Full Text] [Related]
[Next] [New Search]